vs

Side-by-side financial comparison of PETMED EXPRESS INC (PETS) and SPAR Group, Inc. (SGRP). Click either name above to swap in a different company.

PETMED EXPRESS INC is the larger business by last-quarter revenue ($40.7M vs $22.0M, roughly 1.8× SPAR Group, Inc.). PETMED EXPRESS INC runs the higher net margin — -26.0% vs -74.1%, a 48.2% gap on every dollar of revenue. On growth, PETMED EXPRESS INC posted the faster year-over-year revenue change (-23.3% vs -33.4%). SPAR Group, Inc. produced more free cash flow last quarter ($-3.9M vs $-9.2M). Over the past eight quarters, PETMED EXPRESS INC's revenue compounded faster (-20.9% CAGR vs -33.2%).

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

SPAR, originally "DESPAR", styled as "DE SPAR", is a Dutch multinational franchise that provides branding, supplies and support services for independently owned and operated food retail stores. It was founded in the Netherlands in 1932, by Adriaan van Well, although the largest number of stores are located in the United Kingdom.

PETS vs SGRP — Head-to-Head

Bigger by revenue
PETS
PETS
1.8× larger
PETS
$40.7M
$22.0M
SGRP
Growing faster (revenue YoY)
PETS
PETS
+10.1% gap
PETS
-23.3%
-33.4%
SGRP
Higher net margin
PETS
PETS
48.2% more per $
PETS
-26.0%
-74.1%
SGRP
More free cash flow
SGRP
SGRP
$5.3M more FCF
SGRP
$-3.9M
$-9.2M
PETS
Faster 2-yr revenue CAGR
PETS
PETS
Annualised
PETS
-20.9%
-33.2%
SGRP

Income Statement — Q3 FY2026 vs Q4 FY2025

Metric
PETS
PETS
SGRP
SGRP
Revenue
$40.7M
$22.0M
Net Profit
$-10.6M
$-16.3M
Gross Margin
23.3%
-10.6%
Operating Margin
-25.7%
-57.8%
Net Margin
-26.0%
-74.1%
Revenue YoY
-23.3%
-33.4%
Net Profit YoY
-1392.6%
-186.2%
EPS (diluted)
$-0.50
$-0.69

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
PETS
PETS
SGRP
SGRP
Q4 25
$40.7M
$22.0M
Q3 25
$44.4M
$41.4M
Q2 25
$51.2M
$38.6M
Q1 25
$50.8M
$34.0M
Q4 24
$52.0M
$33.0M
Q3 24
$58.0M
$37.8M
Q2 24
$66.2M
$43.4M
Q1 24
$65.1M
$49.4M
Net Profit
PETS
PETS
SGRP
SGRP
Q4 25
$-10.6M
$-16.3M
Q3 25
$-8.5M
$-8.8M
Q2 25
$-34.2M
$-1.0K
Q1 25
$-11.6M
$462.0K
Q4 24
$-707.0K
$-5.7M
Q3 24
$2.3M
$-182.0K
Q2 24
$3.8M
$-3.9M
Q1 24
$-5.0M
$6.6M
Gross Margin
PETS
PETS
SGRP
SGRP
Q4 25
23.3%
-10.6%
Q3 25
28.0%
18.6%
Q2 25
28.1%
23.5%
Q1 25
29.9%
21.4%
Q4 24
31.0%
19.6%
Q3 24
32.3%
22.3%
Q2 24
28.8%
20.7%
Q1 24
29.3%
19.7%
Operating Margin
PETS
PETS
SGRP
SGRP
Q4 25
-25.7%
-57.8%
Q3 25
-18.9%
-14.3%
Q2 25
-66.7%
1.9%
Q1 25
-11.9%
3.0%
Q4 24
-0.9%
-16.6%
Q3 24
1.0%
-4.0%
Q2 24
6.6%
-2.2%
Q1 24
-5.9%
17.6%
Net Margin
PETS
PETS
SGRP
SGRP
Q4 25
-26.0%
-74.1%
Q3 25
-19.2%
-21.2%
Q2 25
-66.7%
-0.0%
Q1 25
-22.9%
1.4%
Q4 24
-1.4%
-17.3%
Q3 24
4.0%
-0.5%
Q2 24
5.7%
-9.0%
Q1 24
-7.7%
13.4%
EPS (diluted)
PETS
PETS
SGRP
SGRP
Q4 25
$-0.50
$-0.69
Q3 25
$-0.41
$-0.37
Q2 25
$-1.65
$0.00
Q1 25
$-0.56
$0.02
Q4 24
$-0.03
$-0.24
Q3 24
$0.11
$-0.01
Q2 24
$0.18
$-0.16
Q1 24
$-0.24
$0.28

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
PETS
PETS
SGRP
SGRP
Cash + ST InvestmentsLiquidity on hand
$26.9M
$3.3M
Total DebtLower is stronger
Stockholders' EquityBook value
$32.8M
$622.0K
Total Assets
$88.0M
$44.1M
Debt / EquityLower = less leverage

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
PETS
PETS
SGRP
SGRP
Q4 25
$26.9M
$3.3M
Q3 25
$36.1M
$8.2M
Q2 25
$41.1M
$13.9M
Q1 25
$54.7M
$17.9M
Q4 24
$50.1M
$18.2M
Q3 24
$52.0M
$19.7M
Q2 24
$46.0M
$21.7M
Q1 24
$55.3M
$16.6M
Stockholders' Equity
PETS
PETS
SGRP
SGRP
Q4 25
$32.8M
$622.0K
Q3 25
$43.1M
$16.6M
Q2 25
$51.5M
$24.9M
Q1 25
$85.1M
$24.7M
Q4 24
$96.2M
$24.3M
Q3 24
$96.4M
$29.3M
Q2 24
$93.5M
$29.4M
Q1 24
$96.7M
$33.0M
Total Assets
PETS
PETS
SGRP
SGRP
Q4 25
$88.0M
$44.1M
Q3 25
$100.3M
$61.7M
Q2 25
$109.8M
$71.6M
Q1 25
$148.7M
$70.2M
Q4 24
$144.8M
$56.4M
Q3 24
$146.0M
$67.4M
Q2 24
$152.7M
$70.0M
Q1 24
$169.9M
$104.5M

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
PETS
PETS
SGRP
SGRP
Operating Cash FlowLast quarter
$-9.2M
$-2.5M
Free Cash FlowOCF − Capex
$-9.2M
$-3.9M
FCF MarginFCF / Revenue
-22.7%
-17.8%
Capex IntensityCapex / Revenue
0.1%
6.6%
Cash ConversionOCF / Net Profit
TTM Free Cash FlowTrailing 4 quarters
$-23.0M
$-21.4M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
PETS
PETS
SGRP
SGRP
Q4 25
$-9.2M
$-2.5M
Q3 25
$-2.2M
$-4.1M
Q2 25
$-12.3M
$-7.9M
Q1 25
$7.0M
$-4.0M
Q4 24
$-1.2M
$65.0K
Q3 24
$7.4M
$-900.0K
Q2 24
$-8.5M
$-445.0K
Q1 24
$7.1M
$615.0K
Free Cash Flow
PETS
PETS
SGRP
SGRP
Q4 25
$-9.2M
$-3.9M
Q3 25
$-4.8M
$-4.6M
Q2 25
$-13.6M
$-8.3M
Q1 25
$4.6M
$-4.6M
Q4 24
$-1.9M
$-166.0K
Q3 24
$6.1M
$-1.0M
Q2 24
$-9.2M
$-785.0K
Q1 24
$5.9M
$184.0K
FCF Margin
PETS
PETS
SGRP
SGRP
Q4 25
-22.7%
-17.8%
Q3 25
-10.8%
-11.2%
Q2 25
-26.5%
-21.5%
Q1 25
9.1%
-13.4%
Q4 24
-3.7%
-0.5%
Q3 24
10.6%
-2.7%
Q2 24
-13.9%
-1.8%
Q1 24
9.0%
0.4%
Capex Intensity
PETS
PETS
SGRP
SGRP
Q4 25
0.1%
6.6%
Q3 25
5.9%
1.4%
Q2 25
2.5%
1.1%
Q1 25
4.7%
1.5%
Q4 24
1.5%
0.7%
Q3 24
2.2%
0.3%
Q2 24
1.0%
0.8%
Q1 24
1.9%
0.9%
Cash Conversion
PETS
PETS
SGRP
SGRP
Q4 25
Q3 25
Q2 25
Q1 25
-8.75×
Q4 24
Q3 24
3.18×
Q2 24
-2.27×
Q1 24
0.09×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

PETS
PETS

Reorder$34.0M84%
New Order$5.0M12%
Membership Fees$1.6M4%

SGRP
SGRP

Segment breakdown not available.

Related Comparisons